Sort
85,873 grants matching “alzheimers”
Preclinical evaluation of tacrolimus in a canine model of Alzheimer's disease
$896,872Elizabeth Head · University Of California-Irvine · R01 · FY2025 · AG
Epidemiology of Dementia in the Framingham Study
$896,854Philip A Wolf · Boston University Medical Campus · R01 · FY2009 · AG
Project 2: Co-pathogenic Interactions between ApoE Isoforms and Abeta in Neural Network Dysfunction of Alzheimer's Disease
$896,684Jorge J Palop · J. David Gladstone Institutes · P01 · FY2025 · AG
Magnetic Resonance Spectroscopy Core Facility
$896,586Jun Shen · National Institute Of Mental Health · ZIC · FY2010 · MH
CLINICAL EPIDEMIOLOGY OF DEMENTIA IN GENERAL PRACTICE
$896,492University Of Pittsburgh At Pittsburgh · R01 · FY2000 · AG
CNS Exosomes-Mediated Adaptive Immunity in Alzheimer's Disease (AD)
$896,099Yongjie Yang · Tufts University Boston · R01 · FY2024 · AG
Antipsychotic Discontinuation in Alzheimer s Disease
$895,987Davangere P Devanand · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2006 · AG
CAMCI: Advancing the Use of Computerized Screening in Healthcare
$895,901Amy Eschman · Psychology Software Tools, Inc. · SB1 · FY2020 · AG
Antipsychotic Discontinuation in Alzheimer s Disease
$895,857New York State Psychiatric Institute · R01 · FY2004 · AG
Development of a transgenic rat to study brain aging
$895,834Inflame Therapeutics, Inc. · R42 · FY2005 · AG
Pilot Collaborative PET Imaging Trial
$895,695University Of Michigan At Ann Arbor · R01 · FY2003 · AG
Epidemiology of Dementia in the Framingham Study
$895,644Philip A Wolf · Boston University Medical Campus · R01 · FY2007 · AG
Project 2 - Imaging of Brain Connrectivity, Structure and Function
$895,592Arthur W Toga · University Of Southern California · P01 · FY2023 · AG
Aberrant protein S-nitrosylation mediates Gene-Environment Interactions in AD/ADRD
$895,482Stuart A Lipton · Scripps Research Institute, The · U01 · FY2025 · AG
Surface Signatures of Neuronal and Glial Extracellular Vesicles
$895,446David Aaron Routenberg · Meso Scale Diagnostics, Llc · UH3 · FY2022 · MH
Surface Signatures of Neuronal and Glial Extracellular Vesicles
$895,420David Aaron Routenberg · Meso Scale Diagnostics, Llc · UH3 · FY2021 · MH
Mechanism and function of autosomal analog of X inactivation
$895,257Alexander Gimelbrant · Dana-Farber Cancer Inst · R01 · FY2014 · GM
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
$895,172Andrea Goldstein-Piekarski · Stanford University · R01 · FY2020 · MH
Neurobiology of Alzheimer's Disease and Aging
$895,000Roger Rosenberg · Ut Southwestern Medical Center · P30 · FY2010 · AG
Core B: Clinical Core
$894,799Jeffrey Murray Burns · University Of Kansas Medical Center · P30 · FY2021 · AG
Tracking autobiographical thoughts: a smartphone-based approach to identifying cognitive correlates of Alzheimer's disease biomarkers and risk factors in clinically normal older adults
$894,758Matthew D Grilli · University Of Arizona · R01 · FY2022 · AG
Preclinical discovery of novel farnesyltransferase inhibitors for the treatment of Alzheimer's disease and related tauopathies
$894,645Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Understanding mechanisms and seeking novel biomarkers in Alzheimer's disease
$894,574Madhav Thambisetty · National Institute On Aging · ZIA · FY2016 · AG
Preoperative Occult Neurodegeneration and Postoperative Delirium
$894,502Gregory Crosby · Brigham And Women'S Hospital · R01 · FY2022 · AG
Project 2: Multi-Ethnic Analysis for Alzheimer Disease
$894,382Giuseppe Tosto · University Of Miami School Of Medicine · U19 · FY2024 · AG